[Molecular epidemiology of fluoroquinolone-resistant Streptococcus pneumoniae in Japan]

Shin-ichi Yokota1, Kiyoshi Sato, Shigeru Yoshida

  • 1Department of Microbiology, Sapporo Medical University School of Medicine.

Insights

Fluoroquinolone resistance in Streptococcus pneumoniae is emerging in Japan, with mutations found in key bacterial genes. This resistance appears to develop sporadically, primarily in older adults.

Area of Science:

  • Microbiology
  • Genetics
  • Pharmacology

Context:

  • Emergence of fluoroquinolone resistance in Streptococcus pneumoniae is a growing global health concern.
  • Surveillance of antimicrobial resistance is crucial for public health, especially in Japan.
  • Previous studies have documented fluoroquinolone resistance in Streptococcus pneumoniae, but specific genetic mechanisms and clonal spread patterns require further investigation.

Purpose:

  • To investigate the prevalence and genetic basis of fluoroquinolone resistance in Streptococcus pneumoniae clinical isolates from Hokkaido, Japan.
  • To analyze the mutation patterns in target genes (parC, parE, gyrA, gyrB) associated with fluoroquinolone resistance.
  • To determine the clonal relatedness of resistant strains using random amplified polymorphic DNA-polymerase chain reaction (RAPD-PCR).

Summary:

  • Eleven fluoroquinolone-resistant Streptococcus pneumoniae strains were identified from 670 clinical isolates collected between 1999 and 2003 in Hokkaido, Japan.
  • All resistant strains showed resistance to ciprofloxacin and levofloxacin, with most also resistant to tosufloxacin, sparfloxacin, and gatifloxacin.
  • Genetic analysis revealed mutations in gyrA, parC, or parE genes, with higher resistance linked to mutations in two genes. RAPD-PCR indicated ten independent clones, suggesting sporadic development of resistance rather than clonal spread.

Impact:

  • The findings highlight the sporadic emergence of fluoroquinolone resistance in Streptococcus pneumoniae, driven by genetic mutations rather than widespread dissemination of resistant clones.
  • The study observed a higher prevalence of resistant strains in adults, particularly those over 60 years old, suggesting age-related susceptibility or exposure patterns.
  • This research contributes to understanding the evolving landscape of antibiotic resistance and informs strategies for antimicrobial stewardship, particularly concerning fluoroquinolone use in different age groups.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...